Apoptosis in Cancer - An Update

  • Sankari, S. Leena (Department of Oral Pathology and Microbiology, Sree Balaji Dental College and Hospital, Bharath University) ;
  • Masthan, K.M.K. (Department of Oral Pathology and Microbiology, Sree Balaji Dental College and Hospital, Bharath University) ;
  • Babu, N. Aravindha (Department of Oral Pathology and Microbiology, Sree Balaji Dental College and Hospital, Bharath University) ;
  • Bhattacharjee, Tathagata (Department of Oral Pathology and Microbiology, Sree Balaji Dental College and Hospital, Bharath University) ;
  • Elumalai, M. (Department of Pharmacology, Sree Balaji Dental College and Hospital, Bharath University)
  • Published : 2012.10.31


Apoptosis is programmed cell death which is essential for development and survival of living organisms. It is a sequentially regulated suicidal programme where cells activate certain enzymes which dissolute their own nuclear component and various protein component of nucleus and cytoplasm. Disturbance of this regulatory pathway may lead to various diseases like autoimmune diseases, neurodegenerative diseases and cancers. The potential mechanisms of apoptosis and its role in cancer are discussed. The ability of apoptosis to modulate the life or death of a cell is also recognized for its immense therapeutic potential. Understanding the mechanisms from this review will give us better insight to the pathogenesis of various diseases including cancer and will open new horizons to therapeutic approaches.


  1. Abou-Nassar K, Brown JR (2010). Novel agents for the treatment of chronic lymphocytic leukaemia. Clin Adv Haematol Oncol, 8, 886-95.
  2. Apoptosis Detection Guide (2010). Enzo Life Sciences Inc. International edition. pp1-14.
  3. Ataur Rahman, Tipu Sultan, Rokibul Islam (2012). Apoptosis and cancer: insights molecular mechanisms and treatments. Int J Biomol and Biomed, 2,1-16.
  4. Boeckler FM, Joerger AC, Jaggi G, et al (2008). Targeted rescue of a destabilised mutant of p53 by an in silico screened drug. Proc Natl Acad Sci USA, 105, 10360-5.
  5. Cheung H-H, Liu X, Rennert OM (2012). Apoptosis: Reprogramming and the fate of mature cells, ISRN Cell Biology, 2012, 1-8.
  6. Curtin JF, Cotter TG (2003). Apoptosis: historical perspectives. Essays Biochem, 39, 1-10.
  7. Deveraux QL, Takahashi R, Salvesen GS, et al (1997). X-linked IAP is a direct inhibitor of cell-death proteases. Nature, 388, 300-4.
  8. Dai Y, Lawrence TS, Xu L (2009). Overcoming cancer therapy resistance by targeting inhibitors of apoptosis proteins and nuclear factor-kappa B. Am J Tranl Res, 1, 1-15.
  9. Dewson G, Kluc RM,(2010) Bcl-2 family-regulated apoptosis in health and disease. Cell Hlth and Cytoskeleton, 2, 9-22.
  10. Elmore S (2007). Apoptosis: a review of programmed cell death. Toxicol Pathol, 35, 495-516.
  11. Gewies A (2003). Apo Review - Introduction to Apoptosis: pp1-26
  12. Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell, 100, 57-70.
  13. Hassen S, Ali N, Chowdhury P (2012) Molecular signaling mechanisms of apoptosis in hereditary non-polyposis colorectal cancer. World J Gastrointest Pathophysiol, 3, 7-79.
  14. Horvitz HR (1999). Genetic control of programmed cell death in the nematode Caenorhabditis elegans. Cancer Res, 59, 1701-6.
  15. Holdenrieder S, Stieber P (2004). The potential of apoptotic markers in diagnostic oncology: as featured in CLI December 2004.
  16. Imawati B, Holt O, Michael L, et al (1999). Biochemical pathways of caspase activation during apoptosis annu. Rev Cell Dev Biol, 15, 269-90.
  17. Kerr JF, Wyllie AH, Currie AR (1972). Apoptosis: a basic, biological phenomenon with wide ranging implications, in tissue kinetics. Br J Cancer, 26, 239-57.
  18. Krejci P, Pejchalova K, Rosenbloom BE, et al (2007). The antiapoptotic protein Api5, and its partner, high molecular weight FGF2, are up-regulated in B cell chronic lymphoid leukemia. J Leukoc Bio, 82, 1363-4.
  19. Masthan KMK, AravindhaBabu N, Kailash CD, et al (2012) Advanced diagnostic aids in oral cancer. Asian Pac J Cancer Prev, 13, 1-4.
  20. Morris EJ, Michaud WA, Ji JY, et al (2006). Functional identification of Api5 as a suppressor of E2Fdependent apoptosis in vivo. PLoS Genetics, 2, 196.
  21. Quinn L, Deveraux, John C Reed (1999). IAP family proteins-suppressors of apoptosis. Genes Dev, 13, 239-52.
  22. Rai KR, Moore J, Wu J, et al (2008). Effect of the addition of oblimersen (Bcl-2 antisense) to fludarabine/cyclophosphamide for replased/refractory chronic lymphocytic leukaemia (CLL) on survival in patients who achieve CR/nPR: Five-year follow-up from a randomized phase III study. J Clin Oncol, 26, 7008.
  23. Ramirez CR, Carracedo AJ, Moreno Aguilary FC, et al (1999). Apoptosis and disease. Alergol Inmunol Clin, 14, 367-4.
  24. Rebecca SY Wong (2011). Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res, 30, 1-14.
  25. Roy N, Deveraux QL, Takahashi R, et al (1997). The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBOJ, 16, 6914-25.
  26. Rigou P,Piddubnyak V,Faye A et al (2009). The antiapoptotic protein AAC-11 interacts with and regulates Acinusmediated DNA fragmentation: The EMBO Journal, 28, 1576-88.
  27. Sasaki H, Moriyama S, Yukiue H, et al (2001). Expression of theantiapoptosis gene, AAC-11, as a prognosis marker in non-small cell lung cancer. Lung Cancer, 34, 53-7.
  28. Schroder M, Kaufman RJ (2005). The mammalian unfolded protein response. Annu Rev Biochem, 74, 739-89.
  29. Searle J, Kerr JFR, Bishop CJ (1982). Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance. Pathol Annu, 17, 229-59.
  30. Seshagiri S, Miller LK (1997). Baculovirus inhibitors of apoptosis (IAPs) block activation of Sf-caspase-1. Proc Natl Acad Sci USA, 94, 13606-11.
  31. Szegezdi E, Fitzgerald U, Samali A (2003). Caspase-12 and ER-stress-mediated apoptosis: the story so far. Ann NY Acad Sci, 1010, 186-94.
  32. Szegezdi E, Logue SE, Gorman AM, et al (2006). Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep, 7, 880-5.
  33. Tewari M, Yu M, Ross B, et al (1997). AAC-11, a novel cDNA that inhibits apoptosis after growth factor withdrawal. Cancer Res, 57, 4063-9.
  34. Tiwari.(2012) Journal of Cancer Therapeutics and Research, pp1 -10)
  35. Van den Berghe L, Laurell H, Huez I et al (2000). FIF [fibroblast growth factor-2 (FGF-2)-interacting-factor],a nuclear putatively antiapoptotic factor, interacts specifically with FGF-2. Mol Endocrinol (Baltimore, Md), 14, 1709-24.
  36. World Health Organization (2010). Cancers the problem, NMH Fact sheet January.
  37. Zinszner H, Kuroda M, Wang X, et al (1998). CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev, 12, 982-95

Cited by

  1. The DNA Repair Gene ERCC6 rs1917799 Polymorphism is Associated with Gastric Cancer Risk in Chinese vol.14, pp.10, 2013,
  2. The radiosensitizing effect of Paeonol on lung adenocarcinoma by augmentation of radiation-induced apoptosis and inhibition of the PI3K/Akt pathway vol.89, pp.12, 2013,
  3. Genome-Wide DNA Methylation Analysis of Human Pancreatic Islets from Type 2 Diabetic and Non-Diabetic Donors Identifies Candidate Genes That Influence Insulin Secretion vol.10, pp.3, 2014,
  4. Treatment with Lingqi capsules suppresses colorectal cancer by inhibiting the hepatocyte growth factor/c-Met signal transduction pathway vol.11, pp.3, 2014,
  5. Rutin mediated targeting of signaling machinery in cancer cells vol.14, pp.1, 2014,
  6. Luteolin Arrests Cell Cycling, Induces Apoptosis and Inhibits the JAK/STAT3 Pathway in Human Cholangiocarcinoma Cells vol.15, pp.12, 2014,
  7. In vitro and In vivo Antitumor Activity of Tiliacorinine in Human Cholangiocarcinoma vol.15, pp.17, 2014,
  8. Induction of Indoleamine 2,3-dioxygenase (IDO) Enzymatic Activity Contributes to Interferon-Gamma Induced Apoptosis and Death Receptor 5 Expression in Human Non-small Cell Lung Cancer Cells vol.15, pp.18, 2014,
  9. Label free high throughput screening for apoptosis inducing chemicals using time-lapse microscopy signal processing vol.19, pp.9, 2014,
  10. Novel mechanisms involving chemically modified tetracycline 3 cytotoxicity vol.25, pp.10, 2014,
  11. Downregulation of Rap1 promotes 5-fluorouracil-induced apoptosis in hepatocellular carcinoma cell line HepG2 vol.31, pp.4, 2014,
  12. Diallyl disulfide induces G2/M arrest and promotes apoptosis through the p53/p21 and MEK-ERK pathways in human esophageal squamous cell carcinoma vol.32, pp.4, 2014,
  13. Epigallocatechin-3-gallate (EGCG) protects skin cells from ionizing radiation via heme oxygenase-1 (HO-1) overexpression vol.55, pp.6, 2014,
  14. Fish oil administration mediates apoptosis of Walker 256 tumor cells by modulation of p53, Bcl-2, caspase-7 and caspase-3 protein expression vol.14, pp.1, 2015,
  15. An in silico Appraisal to Identify High Affinity Anti-Apoptotic Synthetic Tetrapeptide Inhibitors Targeting the Mammalian Caspase 3 Enzyme vol.15, pp.23, 2015,
  16. Steroidal Saponins from Paris polyphylla Induce Apoptotic Cell Death and Autophagy in A549 Human Lung Cancer Cells vol.16, pp.3, 2015,
  17. Hyperthermia: an effective strategy to induce apoptosis in cancer cells vol.20, pp.11, 2015,
  18. Effect of ERCC8 tagSNPs and their association with H. pylori infection, smoking, and alcohol consumption on gastric cancer and atrophic gastritis risk vol.36, pp.12, 2015,
  19. Dysregulation of the PI3K/Akt signaling pathway affects cell cycle and apoptosis of side population cells in nasopharyngeal carcinoma pp.1792-1082, 2015,
  20. Proteasome inhibitor mg‑132 enhances histone deacetylase inhibitor saha‑induced cell death of chronic myeloid leukemia cells by an ros‑mediated mechanism and downregulation of the bcr‑abl fusion protein pp.1792-1082, 2015,
  21. Dihydroartemisinin suppresses growth of squamous cell carcinoma A431 cells by targeting the Wnt/β-catenin pathway vol.27, pp.2, 2016,
  22. Oncogenic function of Plac1 on the proliferation and metastasis in hepatocellular carcinoma cells vol.37, pp.1, 2016,
  23. B Signalings Are Critically Involved in Dieckol Induced Antihepatic Fibrosis vol.64, pp.27, 2016,
  24. Antiproliferative and proapoptotic activity of Turkish propolis on human lung cancer cell line vol.68, pp.1, 2016,
  25. Luteolin induces cholangiocarcinoma cell apoptosis through the mitochondrial-dependent pathway mediated by reactive oxygen species vol.68, pp.9, 2016,
  26. -inden-2-ylidene)methyl)phenyl)-3-phenylurea Derivatives vol.14, pp.10, 2017,
  27. Isolation and characterization of three new anti-proliferative Sesquiterpenes from Polygonum barbatum and their mechanism via apoptotic pathway vol.17, pp.1, 2017,
  28. CHAC2, downregulated in gastric and colorectal cancers, acted as a tumor suppressor inducing apoptosis and autophagy through unfolded protein response vol.8, pp.8, 2017,
  29. A study of the potential anticancer activity of Mangifera zeylanica bark: Evaluation of cytotoxic and apoptotic effects of the hexane extract and bioassay-guided fractionation to identify phytochemical constituents vol.11, pp.2, 2016,
  30. MicroRNA-24-1-5p promotes malignant melanoma cell autophagy and apoptosis via regulating ubiquitin D vol.16, pp.6, 2017,
  31. BCI induces apoptosis via generation of reactive oxygen species and activation of intrinsic mitochondrial pathway in H1299 lung cancer cells vol.61, pp.10, 2018,